Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Other solid neoplasm 1Gynecologic 1Genitourinary 1Breast 1

Conditions

Breast Neoplasms 7Triple Negative Breast Neoplasms 4Ovarian Neoplasms 2Uterine Cervical Neoplasms 1Stomach Neoplasms 1Prostatic Neoplasms 1Penile Neoplasms 1Pathologic Complete Response 1Mesothelioma, Malignant 1Lung Neoplasms 1Brain Neoplasms 1

Interventions

entinostat 1Ritonavir 1Radiotherapy 1Quality of Life 1Psychiatric Rehabilitation 1Platinum 1Patient Reported Outcome Measures 1Nivolumab 1Molecular Diagnostic Techniques 1Magnetic Resonance Spectroscopy 1Indinavir 1Immunotherapy 1Immunohistochemistry 1Gemcitabine 1Ganciclovir 1Fluorodeoxyglucose F18 1Fentanyl 1FAPI-46 1Early Intervention, Educational 1Drug Therapy 1Counseling 1Cisplatin 1Biopsy 1Biological Therapy 1BAY 1895344 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Penile Neoplasms × Platinum × Breast × Clear all
NCT04491942 2026-04-13

Testing the Addition of an Anti-cancer Drug, BAY 1895344, to the Usual Chemotherapy Treatment (Cisplatin, or Cisplatin and Gemcitabine) for Advanced Solid Tumors With Emphasis on Urothelial Cancer

National Cancer Institute (NCI)

Phase 1 Active not recruiting
74 enrolled
BreastGenitourinaryGynecologicOther solid neoplasmThoracic

Mesothelioma, Malignant, Uterine Cervical Neoplasms, Lung Neoplasms, Ovarian Neoplasms, Penile Neoplasms, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡